Ibrutinib does not have clinically relevant interactions with oral contraceptives or substrates of CYP3A and CYP2B6

  1. de Jong, J.
  2. Mitselos, A.
  3. Jurczak, W.
  4. Cordoba, R.
  5. Panizo, C.
  6. Wrobel, T.
  7. Dlugosz-Danecka, M.
  8. Jiao, J.
  9. Sukbuntherng, J.
  10. Ouellet, D.
  11. Hellemans, P.
Journal:
Pharmacology Research and Perspectives

ISSN: 2052-1707

Year of publication: 2020

Volume: 8

Issue: 5

Type: Article

DOI: 10.1002/PRP2.649 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus